17
Views
10
CrossRef citations to date
0
Altmetric
Research Papers

Retina in rheumatic diseases: Standard full field and multifocal electroretinography in hydroxychloroquine retinal dysfunction

, MD, , PhD, , MD, , PhD &
Pages 276-283 | Received 22 Jul 2009, Accepted 11 Feb 2010, Published online: 15 Apr 2021
 

Abstract

Background:  The purpose of this study was to evaluate and compare full‐field electroretinography (ERG) and multifocal electroretinography (mfERG) results in detecting retinal dysfunction in a large number of asymptomatic patients treated with hydroxychloroquine (Hy).

Methods:  Fifty eyes in 50 patients with rheumatic diseases who had been using Hy for a period of time ranging from 30-months to 15-years, and 25 eyes in 25 healthy controls, were evaluated. Receiver operator characteristic (ROC) curves were calculated to determine the sensitivity and specificity of abnormal values in patients compared to the normal controls.

Results:  Signal depression was observed on the mfERG of Hy‐treated patients. The most prevalent pattern was pericentral loss (19 eyes, 54.3 per cent), followed by full‐field loss (11 eyes, 31.4 per cent), and central loss (five eyes, 14.3 per cent). Conversely, depression of the amplitude responses to the full field ERG was observed in only 16 per cent of the cases. The areas under the ROC curves ranged from 0.4056 to 0.9012, with the mfERG values having the largest areas, whereas the full‐field ERG curves had the smallest area. The mfERG responses yielded the greatest sensitivity and specificity. In particular, the P1‐N1 wave amplitude (ring 2) and root mean square (RMS) amplitude (ring 1) had specificities of 76 and 88 per cent, respectively, at sensitivities of 90 and 86 per cent.

Conclusion:  A statistically significant retinal functional impairment was demonstrated by mfERG in the central two to 10 degrees in Hy‐treated patients. Therefore, mfERG may provide an objective measurement of retinal dysfunction in patients receiving Hy therapy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.